Search Results
Clinical trials aiming to reduce the toxicity of novel agents in AML
The Truth About Clinical Trials in AML
Case study | Treatment, side effects, and clinical trials
AML: novel conditioning and maintenance strategies
AML17 Trial results: maximum dosage of daunorubicin in AML
Acute myeloid leukemia (AML): Expanding access to novel treatment and care, 2024 Leukemia Conference
The current role of immuno-oncology in AML and future outlooks
Making Sense of Diagnosing and Treating AML | January 26th, 2022 #AML
Dr Richard Dillon - AML Diagnostics and Management at the Molecular Level
Should antifungal prophylaxis be used in patients with AML who are treated with novel agents?
Impact of cytogenetic abnormalities on OS following SCT in pediatric AML
Oral azacitidine maintenance therapy for post-transplant AML
